Luye Pharma enters into agreement with Cipla Medpro

Pharma |  News | 0 Comment | 11 Feb, 2020

Luye Pharma Group, with R&D centers in China, the U.S. and Europe, has announced that it has entered into an exclusive distribution and marketing service agreement with Cipla ...Read more

AstraZeneca invests $200M for manufacturing in Australia

Pharma |  News | 1 Comment | 10 Feb, 2020

AstraZeneca has committed $200 million to the company’s manufacturing facility in North Ryde, Sydney, Australia. The investment follows $100 million announced in 2017 and will go towa...Read more

Chugai collaborates with National Cancer Center

Pharma |  News | 0 Comment | 10 Feb, 2020

Japanese firm Chugai Pharmaceutical Co., Ltd. has announced that it has entered into an agreement with National Cancer Center, Japan to support an investigator-initiated clinical study base...Read more

Curis, Aurigene announce amendment of collaboration

Pharma |  News | 0 Comment | 10 Feb, 2020

US based Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, has announced that it has entered into an amendment of its c...Read more

Stevanato Group collaborates with Bormioli Pharma

Pharma |  News | 0 Comment | 06 Feb, 2020

Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, and Bormioli Pharma have announced a collaboration agreement. The agreement will e...Read more

20th Anniversary ISPE Singapore Affiliate Conference opens "Call for Papers"

Pharma |  News | 0 Comment | 06 Feb, 2020

The International Society for Pharmaceutical Engineering (ISPE) Singapore Affiliate is pleased to announce that the 20th Anniversary of the Singapore conference is now confirmed for 26 to 2...Read more

USFDA approves first emergency coronavirus diagnostic test

Pharma |  News | 0 Comment | 06 Feb, 2020

The U.S Food and Drug Administration (US FDA) issued an emergency use authorization (EUA) to enable emergency use of the Centers for Disease Control and Prevention’s (CDC) 2...Read more

MediPharm Labs receives Australian licence to import drugs

Pharma |  News | 0 Comment | 05 Feb, 2020

Canada based MediPharm Labs Corp., a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce the rece...Read more

Ocumension inks $14M deal with EyePoint Pharma

Pharma |  News | 0 Comment | 04 Feb, 2020

US based EyePoint Pharmaceuticals, Inc., a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, and Ocumension Therapeutics, a fast-growing ...Read more

Avacta, Daewoong Pharma collaborate with AffyXell

Pharma |  News | 0 Comment | 04 Feb, 2020

UK based Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has signed a collaboration and license agreement with AffyXell The...Read more

Sumitomo Dainippon, Exscientia begin clinical study of AI based OCD drug

Pharma |  News | 0 Comment | 03 Feb, 2020

Japan based Sumitomo Dainippon Pharma Co., Ltd. and UK based Exscientia Ltd. have announced that a phase I clinical study of DSP-1181, that was created using Artificial Intelligence (AI), h...Read more

JT to market CORECTIM in Japan to treat atopic dermatitis

Pharma |  News | 0 Comment | 30 Jan, 2020

Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. (Torii) have announced that JT has received manufacturing and marketing approval for CORECTIM® Ointment 0.5% (generic name: delgoci...Read more

Pharmapack Europe unpacks key drivers and challenges in 2020

Pharma |  News | 0 Comment | 28 Jan, 2020

Pharmapack Europe organised by Informa Markets, will take place next week at the Porte De Versailles in Paris (5-6 February, 2020). The event has pinpointed a number of opportunities and t...Read more

Sartorius is set to grow further

Pharma |  News | By Ankit Kankar | 0 Comment | 28 Jan, 2020

Key Facts  Group sales revenue up 14.8%; order intake up 14.8%; underlying EBITDA margin 27.1%  Continued strong growth for the Bioprocess Solutions Division, robust develop...Read more

Eisai’s DAYVIGO gets approval in Japan to treat insomnia

Pharma |  News | 0 Comment | 28 Jan, 2020

Japanese firm Eisai Co., Ltd has obtained the manufacturing and marketing approval in Japan for its in-house discovered orexin receptor antagonist DAYVIGOTM (2.5mg, 5mg, and 10mg table...Read more

China SXT Pharma to increase production

Pharma |  News | 0 Comment | 27 Jan, 2020

China SXT Pharmaceuticals, a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs") has...Read more

Amgen Astellas Biopharma to become wholly owned Amgen affiliate

Pharma |  News | 0 Comment | 28 Jan, 2020

Amgen, Astellas Pharma and Amgen Astellas BioPharma K.K. announced that on April 1, 2020, Amgen will purchase the 49% of shares in Amgen Astellas BioPharma that are held by Astellas, based ...Read more

Eisai gets approval of anti-epileptic drug in Japan

Pharma |  News | 0 Comment | 27 Jan, 2020

Japanese firm Eisai Co., Ltd. has obtained the approvals of supplementary new drug applications in Japan for its in-house developed antiepileptic drug (AED) Fycompa (perampanel) for an addi...Read more